Markets:

Overview

News

Currencies

International

Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

10.04 +0.96 (+10.57%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock ↗

May 02, 2024

Carvana stock is climbing higher on Thursday after shares of CVNA got an increased price target and upgrade from JPMorgan analyst Rajat Gupta.

Via InvestorPlace

Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts ↗

May 02, 2024

Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities.

Via InvestorPlace

Topics Workforce

Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results ↗

May 02, 2024

Via Benzinga

Why Is Freshworks (FRSH) Stock Down 17% Today? ↗

May 02, 2024

Freshworks stock is falling on Thursday as FRSH investors learn of its CEO stepping down and react to lackluster 2024 guidance.

Via InvestorPlace

Why Is Fastly (FSLY) Stock Down 36% Today? ↗

May 02, 2024

Fastly stock is falling on Thursday as FSLY investors react to weak guidance and mixed results in its earnings report for Q1 2024.

Via InvestorPlace

Emergent BioSolutions: Q4 Earnings Insights ↗

March 06, 2024

Via Benzinga

Why Is Carvana (CVNA) Stock Up 36% Today? ↗

May 02, 2024

Carvana stock is up on Thursday after the company surprised CVNA investors with record profits and revenue during the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 02, 2024

Via Benzinga

Why Is Emergent BioSolutions (EBS) Stock Up 57% Today? ↗

May 02, 2024

Emergent BioSolutions stock is up on Thursday after the life sciences company posted a surprising profit and strong earnings in Q1 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 02, 2024

Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!

Via InvestorPlace

Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket ↗

May 02, 2024

Via Benzinga

Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript ↗

May 01, 2024

EBS earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

EBS stock results show that Emergent BioSolutions beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Emergent BioSolutions Reports First Quarter 2024 Financial Results

May 01, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

May 01, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

May 01, 2024

From Emergent BioSolutions

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 01, 2024

Via Benzinga

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

April 30, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024

April 22, 2024

From Emergent BioSolutions

Via GlobeNewswire

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

April 01, 2024

Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

March 28, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

March 25, 2024

From Emergent BioSolutions

Via GlobeNewswire

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 07, 2024

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 07, 2024

Via Benzinga

Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket ↗

March 07, 2024

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 07, 2024

Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!

Via InvestorPlace

Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript ↗

March 06, 2024

EBS earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023 ↗

March 06, 2024

EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement ↗

March 06, 2024

Emergent BioSolutions reported quarterly losses of 77 cents per share, missing the analyst consensus estimate of losses of 19 cents per share. Quarterly sales came in at $276.6 million which missed the...

Via Benzinga

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

March 06, 2024

From Emergent BioSolutions

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Emergent BioSolutions Inc. Common Stock (NY:EBS)

All News about Emergent BioSolutions Inc. Common Stock

Starting at $3.75/week.

Subscribe Today